Gadofosveset

Chemical formula: C₃₃H₃₈GdN₃Na₃O₁₄P  Molecular mass: 1,003.85 g/mol  PubChem compound: 73049652

Active ingredient description

Gadofosveset is a formulation of a stable gadolinium diethylenetriaminepentaacetic acid (GdDTPA) chelate substituted with a diphenylcyclohexylphosphate group (gadofosveset trisodium), for use in magnetic resonance imaging (MRI). Gadofosveset binds reversibly to human serum albumin.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
V08CA11 Gadofosveset V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA11

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
ABLAVAR Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 193901-90-5
DrugBank Drug: DB06705
KEGG Drug: D04286
PubChem Compound: 73049652
RxNorm Ingredient: 1364290
SNOMED-CT Concept: 420466007
Gadofosveset (substance)
UNII Identifier: E65RW73PHS
GADOFOSVESET

Medicines

Gadofosveset is an active ingredient of these brands:

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.